Systematic reviews have revealed that GLP-1RAs exert bidirectional modulatory effects on cancer risk, with outcomes varying depending on cancer type, patient characteristics, and study methodology
The prospect of combining health benefits, including improved metabolic outcomes and reduced cardiovascular risks, adds another layer of optimism
Here are some conditions that can mean you should skip it: Pancreatitis: If youve experienced inflammation of your pancreas before, Byetta might increase the risk of it happening again because it can cause or exacerbate pancreatic inflammation
Besides, only in a minority of patients, elevation of pancreatic or liver enzymes was seen, resulting in no pancreatitis and/or cholelithiasis occurrence, which was also verified in a recent meta-analysis showing that treatment with GLP-1-RAs is not associated with increased risk for acute pancreatitis, renal failure, or malignant neoplasms [43]
These conditions can cause imbalances in the systems regulating your peptides and hormones
Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. Journal of Translational Medicine